Tharimmune Cash Per Share from 2010 to 2025

THAR Stock   1.44  0.11  7.10%   
Tharimmune Cash Per Share yearly trend continues to be relatively stable with very little volatility. Cash Per Share is likely to grow to 118.74 this year. During the period from 2010 to 2025, Tharimmune Cash Per Share destribution of quarterly values had range of 216 from its regression line and mean deviation of  53.08. View All Fundamentals
 
Cash Per Share  
First Reported
2010-12-31
Previous Quarter
113.09
Current Value
118.74
Quarterly Volatility
66.93968576
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Tharimmune financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tharimmune's main balance sheet or income statement drivers, such as Net Interest Income of 128.6 K, Interest Expense of 18 K or Selling General Administrative of 7.1 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.0688. Tharimmune financial statements analysis is a perfect complement when working with Tharimmune Valuation or Volatility modules.
  
Check out the analysis of Tharimmune Correlation against competitors.
To learn how to invest in Tharimmune Stock, please use our How to Invest in Tharimmune guide.

Latest Tharimmune's Cash Per Share Growth Pattern

Below is the plot of the Cash Per Share of Tharimmune over the last few years. It is Tharimmune's Cash Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tharimmune's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.00 X10 Years Trend
Slightly volatile
   Cash Per Share   
       Timeline  

Tharimmune Cash Per Share Regression Statistics

Arithmetic Mean37.14
Geometric Mean4.22
Coefficient Of Variation180.22
Mean Deviation53.08
Median1.39
Standard Deviation66.94
Sample Variance4,481
Range216
R-Value0.68
Mean Square Error2,563
R-Squared0.47
Significance0
Slope9.60
Total Sum of Squares67,214

Tharimmune Cash Per Share History

2025 118.74
2024 113.09
2023 125.65
2022 215.74
2021 0.14
2020 6.99

About Tharimmune Financial Statements

Tharimmune shareholders use historical fundamental indicators, such as Cash Per Share, to determine how well the company is positioned to perform in the future. Although Tharimmune investors may analyze each financial statement separately, they are all interrelated. The changes in Tharimmune's assets and liabilities, for example, are also reflected in the revenues and expenses on on Tharimmune's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Cash Per Share 113.09  118.74 

Pair Trading with Tharimmune

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Tharimmune position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tharimmune will appreciate offsetting losses from the drop in the long position's value.

Moving together with Tharimmune Stock

  0.82CDIOW Cardio DiagnosticsPairCorr
  0.73ELVN Enliven TherapeuticsPairCorr

Moving against Tharimmune Stock

  0.79LUCD Lucid DiagnosticsPairCorr
  0.74WM Waste ManagementPairCorr
  0.55GE GE AerospacePairCorr
  0.55PG Procter GamblePairCorr
  0.33PLX Protalix BiotherapeuticsPairCorr
The ability to find closely correlated positions to Tharimmune could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Tharimmune when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Tharimmune - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Tharimmune to buy it.
The correlation of Tharimmune is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Tharimmune moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Tharimmune moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Tharimmune can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Additional Tools for Tharimmune Stock Analysis

When running Tharimmune's price analysis, check to measure Tharimmune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tharimmune is operating at the current time. Most of Tharimmune's value examination focuses on studying past and present price action to predict the probability of Tharimmune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tharimmune's price. Additionally, you may evaluate how the addition of Tharimmune to your portfolios can decrease your overall portfolio volatility.